Efanesoctocog alfa Clinical Trials

1 actively recruiting trial

Also known as: Altuviiio, Altuvoct, BIVV001, Recombinant coagulation factor VIII Fc-von-Willebrand Factor-XTEN fusion protein (rFVIIIFc-VWF-XTEN)

Pipeline

Phase 3: 1

Top Sponsors

Swedish Orphan Biovitrum1

Indications

Haemophilia A (Moderate or Severe)1
Cancer1

Other1 trial

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.